How much funding has Raythera raised?

Raythera has raised $110.0M in total funding, most recently a Series A round.

Who are Raythera's investors?

Raythera's investors include Foresite Capital, OrbiMed, TTM Capital, HM Capital, 3E Bioventures Capital.

Where is Raythera headquartered?

Raythera is headquartered in San Diego, California, United States.

Raythera

Innovating Breakthrough Therapies for Unmet Medical Needs

San Diego, United States · Founded 2023 · $110.0M raised

Biotech

Headquarters: San Diego, California
Employees: 1–10
Founded: 2023
Business Model: B2B

Website: raythera.com
Total Funding: $110.0M
Last Round: $110.0M Series AApr 2025
Rounds: 1

About

RayThera is a San Diego-based biotechnology company founded in 2023, focused on discovering and developing small molecule therapies for critical unmet needs in immunology. Backed by Foresite Capital, OrbiMed, and TTM Capital, the company combines decades of drug discovery expertise with an agile approach to accelerate development of transformative immunology treatments.

Summary

Raythera is a Biotech company based in San Diego, United States, founded in 2023. It has raised $110.0M in total across 1 round, most recently a $110.0M Series A round in Apr 2025. Investors include Foresite Capital, OrbiMed and TTM Capital.